EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma

Otilia Kimpel, Barbara Altieri iD, Ulrich Dischinger, Carmina Teresa Fuss, Max Kurlbaum, Martin Fassnacht iD

Metabolites · 28.12.2023 · 14 (1) · 20

DOI: 10.3390/metabo14010020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 28.12.2023. Verfasst von Otilia Kimpel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung & the Eva Luise und Horst Köhler Stiftung and the German Research Foundation (DFG) project 314061271 (TRR-CRC 205)., the Clinician Scientist programme RISE, Else Kröner-Fresenius-Stiftung & the Eva Luise und Horst Köhler Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum liquid chromatography–tandem mass spectrometry (LC–MS/MS) steroid profiling is used for the diagnosis of adrenocortical carcinoma (ACC). Guidelines recommend endocrine work-up in addition to radiological imaging for follow-up in ACC, but data on this topic are scarce. Patients were included in this retrospective study if pre-therapeutic hormone values, regular tumour evaluation by imaging, steroid measurements by LC–MS/MS, and details on therapies were available. The utility of steroid profiles in detecting recurrence or disease progression was assessed, whereby “endocrine progress” was defined by an elevation of at least 3 of 13 analysed hormones. Cohort A included 47 patients after R0 resection, of whom 15 experienced recurrence and 32 did not. In cohort B, 52 patients with advanced disease (including 7 patients of cohort A with recurrence) could be evaluated on 74 visits when progressive disease was documented. In 20 of 89 cases with documented disease progression, “endocrine progress” was detectable prior to radiological progress. In these cases, recurrence/progression was detected at a median of 32 days earlier by steroid measurement than by imaging, with 11-deoxycortisol and testosterone being the most sensitive markers. Notably, these patients had significantly larger tumour burden. In conclusion, steroid profiling by LC–MS/MS is of value in detecting recurrent/progressive disease in ACC.

Schlagwörter

Stichwörter der Autor:innen

adrenal cancerfollow-upliquid chromatography–tandem mass spectrometry (LC–MS/MS)steroid measurement

Autor:innen und Institutionen

  • Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, University of Würzburg, 97080 Würzburg, Germany.
  • Core Unit Clinical Mass Spectrometry, Central Laboratory, University Hospital Würzburg, 97080 Würzburg, Germany.
  • Comprehensive Cancer Center Mainfranken, University of Würzburg, 97080 Würzburg, Germany.

ORCID-Profile: Barbara Altieri, Martin Fassnacht

Förderung

  • Else Kröner-Fresenius-Stiftung & the Eva Luise und Horst Köhler Stiftung and the German Research Foundation (DFG) project 314061271 (TRR-CRC 205).
  • the Clinician Scientist programme RISE
  • Else Kröner-Fresenius-Stiftung & the Eva Luise und Horst Köhler Stiftung
  • German Research Foundation

Zitieren

APA

Kimpel, O., Altieri, B., Dischinger, U., Fuss, C. T., Kurlbaum, M., & Fassnacht, M. (2023). Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma. Metabolites, 14(1), 20. https://doi.org/10.3390/metabo14010020

Vancouver

Kimpel O, Altieri B, Dischinger U, Fuss CT, Kurlbaum M, Fassnacht M. Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma. Metabolites. 2023;14(1):20. doi:10.3390/metabo14010020

BibTeX
@article{Kimpel2023,
  author = {Kimpel, Otilia and Altieri, Barbara and Dischinger, Ulrich and Fuss, Carmina Teresa and Kurlbaum, Max and Fassnacht, Martin},
  title = {Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC–MS/MS in Patients with Adrenocortical Carcinoma},
  journal = {Metabolites},
  year = {2023},
  volume = {14},
  number = {1},
  pages = {20},
  doi = {10.3390/metabo14010020}
}
Kostenlos starten →